Article
The FDA announced that it granted two additional approvals to Syneron Medical Ltd. and its North American subsidiary, Syneron Inc., for the company's hair removal and skin rejuvenation devices.
Combining Minoxidil and LLLT Does Not Improve Treatment Outcomes for Androgenic Alopecia
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Pearls for Treatment Selection and Managing Adverse Effects in Hyperhidrosis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Reviewing Complex Cases: Psoriasis in Older Patients
Novel RF and HIFES Device is Effective for Enhancing Facial Laxity Among Asian Patients